- Home
- OABI vs HOUS Comparison
OABI vs HOUS Comparison
Compare OABI & HOUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- HOUS
- Stock Information
- Founded
- OABI 2012
- HOUS 2006
- Country
- OABI United States
- HOUS United States
- Employees
- OABI N/A
- HOUS N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- HOUS Real Estate
- Sector
- OABI Health Care
- HOUS Finance
- Exchange
- OABI Nasdaq
- HOUS Nasdaq
- Market Cap
- OABI 307.4M
- HOUS 368.3M
- IPO Year
- OABI N/A
- HOUS 2006
- Fundamental
- Price
- OABI $2.28
- HOUS $3.34
- Analyst Decision
- OABI Strong Buy
- HOUS Sell
- Analyst Count
- OABI 3
- HOUS 1
- Target Price
- OABI $7.00
- HOUS $3.00
- AVG Volume (30 Days)
- OABI 780.2K
- HOUS 1.2M
- Earning Date
- OABI 03-18-2025
- HOUS 04-24-2025
- Dividend Yield
- OABI N/A
- HOUS N/A
- EPS Growth
- OABI N/A
- HOUS N/A
- EPS
- OABI N/A
- HOUS N/A
- Revenue
- OABI $26,391,000.00
- HOUS $5,692,000,000.00
- Revenue This Year
- OABI $77.72
- HOUS $5.17
- Revenue Next Year
- OABI $30.95
- HOUS $5.75
- P/E Ratio
- OABI N/A
- HOUS N/A
- Revenue Growth
- OABI N/A
- HOUS 0.99
- 52 Week Low
- OABI $2.23
- HOUS $2.71
- 52 Week High
- OABI $5.54
- HOUS $6.19
- Technical
- Relative Strength Index (RSI)
- OABI 27.98
- HOUS 42.19
- Support Level
- OABI $2.38
- HOUS $3.65
- Resistance Level
- OABI $2.57
- HOUS $3.88
- Average True Range (ATR)
- OABI 0.18
- HOUS 0.21
- MACD
- OABI -0.04
- HOUS -0.03
- Stochastic Oscillator
- OABI 4.42
- HOUS 7.23
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).